WeVote
Log In

Bill

Bill

SB 1225

pharmacies; cost sharing requirement; rebates

57th Legislature - Second Regular Session Introduced by Brian Fernandez

SB 1225 regulates Arizona pharmacy cost-sharing requirements and rebate practices to improve patient drug pricing transparency and affordability.

Senate First Reading
0
WeVote Research Nonpartisan
Bill Summary · SB 1225

Legislative bill overview

SB 1225 addresses how pharmacies handle cost-sharing requirements and rebates in Arizona. The bill appears to regulate the relationship between pharmacy cost-sharing obligations and pharmaceutical rebate programs, likely establishing requirements for how rebates affect patient out-of-pocket costs. Without access to the full bill text, the precise mechanisms cannot be detailed, but the focus is on transparency and fairness in pharmacy pricing practices.

Why is this important

Pharmacy cost-sharing directly impacts patients' medication affordability and access to treatment. Rebate programs between drug manufacturers and insurers/pharmacy benefit managers can create situations where patients pay high out-of-pocket costs even when rebates reduce the actual drug price, raising questions about who benefits from cost negotiations. Clarifying these relationships affects millions of Arizonans purchasing prescriptions.

Potential points of contention

  • Rebate pass-through disputes: Whether rebates must be passed to patients at point-of-sale or can be retained by insurers/intermediaries, affecting who captures savings
  • Pharmacy margin protection: Community pharmacies versus chain pharmacies may have different interests in rebate structures and cost-sharing limits
  • Insurer and PBM opposition: Health plans and pharmacy benefit managers may resist requirements that reduce their rebate revenue or administrative flexibility

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.